Iododoxorubicin
Iododoxorubicin is a derivative of Doxorubicin (HY-15142A) and anticancer agent. Iododoxorubicin has stronger activity against Lewis lung carcinoma than Doxorubicin.
For research use only. We do not sell to patients.
- CAS No.: 83997-75-5
- Formula: C27H28INO10
- Molecular Weight:653.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 83997-75-5
-
Molecular Weight 653.42
-
Formula C27H28INO10
-
SMILES
[H][C@]1(O[C@H]2C[C@@](CC3=C(C(C(C4=C5C(OC)=CC=C4)=O)=C(C(O)=C23)C5=O)O)(C(CO)=O)O)C[C@@H]([C@@H]([C@@H](O1)C)I)N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Berger I, et al. Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG). Nucleic Acids Res. 1995 Nov 11;23(21):4488-94. [Content Brief]
[2]. Twelves CJ, et al. Dobbs NA, Lawrence MA, Ramirez AJ, Summerhayes M, Richards MA, Towlson KE, Rubens RD. Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life. Br J Cancer. 1994 Apr;69(4):726-31. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)